Inappropriately normal plasma ACTH and cortisol concentrations in the face of increased circulating interleukin-6 concentration in exercise in patients with sarcoidosis

Stress

Volumn 16, Issue 2, 2013, Pages 202-210

  Mastorakos, George ^a   Paltoglou, George ^a   Greene, Maria ^b   Ilias, Ioannis ^c   Papamichalopoulos, Antonios ^d   Dimopoulos, Stavros ^d   Pouliou, Eleni ^d   Fatouros, Ioannis G ^c   Nanas, Serafim ^d  

^a UNIVERSITY OF ATHENS   (Greece)

^b CHILDREN'S MEMORIAL HOSPITAL   (United States)

^c DEMOCRITUS UNIVERSITY OF THRACE   (Greece)

^d UNIVERSITY OF ATHENS   (Greece)

Author keywords

Adrenocorticotropic hormone; Cortisol; Interleukin 6; Sarcoidosis; Treadmill exercise; Tumor necrosis factor

Indexed keywords

CORTICOTROPIN; DEXAMETHASONE; HYDROCORTISONE; INTERLEUKIN 1BETA; INTERLEUKIN 6; TUMOR NECROSIS FACTOR;

ADULT; ARTICLE; CLINICAL ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; CORTICOTROPIN BLOOD LEVEL; FEMALE; HORMONE DETERMINATION; HUMAN; HYDROCORTISONE BLOOD LEVEL; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; MALE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BLOOD LEVEL; SARCOIDOSIS; STIMULATION; TREADMILL EXERCISE; TREATMENT RESPONSE;

ADRENOCORTICOTROPIC HORMONE; ADULT; EXERCISE; EXERCISE TEST; FEMALE; HUMANS; HYDROCORTISONE; INTERLEUKIN-1BETA; INTERLEUKIN-6; MALE; MIDDLE AGED; SARCOIDOSIS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84873335856     PISSN: 10253890     EISSN: 16078888     Source Type: Journal    
DOI: 10.3109/10253890.2012.715221     Document Type: Article

References (44)

1. Ainsworth BE, Haskell WL, Herrmann SD, Meckes N, Bassett DR, Jr, Tudor-Locke C, Greer JL, Vezina J, Whitt-Glover, MC, Leon AS. 2011. Compendium of Physical Activities: a second update of codes andMETvalues. Med Sci Sports Exerc 43:1575-1581.
2. American College ofSports Medicine. 2006. Guidelines forexercise testing and prescription. Philadelphia, PA: Lippincott Williams & Wilkins.
3. Antoniou KM, Tzanakis N, Tzouvelekis A, Samiou M, Symvoulakis EK, Siafakas NM, Bouros D. 2006. Quality oflife in patients with active sarcoidosis in Greece. Eur J Intern Med 17:421-426.
4. Ardic I, Kaya MG, Yarlioglues M, Dogdu O, Buyukoglan H, Kalay N, Kanbay A, Zencir C, Ergin A. 2011. Impaired heart rate recovery index in patients with sarcoidosis. Chest 139:60-68.
5. Balamugesh T, Behera D, Bhatnagar A, Majumdar S. 2006. Inflammatory cytokine levels in induced sputum and bronch-oalveolar lavage fluid in pulmonary sarcoidosis. Indian J Chest Dis Allied Sci 48:177-181.
6. Bansal AS, Bruce J, Hogan PG, Allen RK. 1997. An assessment of peripheral immunity in patients with sarcoidosis using measure-ments ofserum vitamin D3, cytokines and soluble CD23. Clin Exp Immunol 110:92-97.
7. Buske-Kirschbaum A, Ebrecht M, Hellhammer DH. 2010. Blunted HPA axis responsiveness to stress in atopic patients is associated with the acuity and severeness of allergic inflammation. Brain Behav Immun 24:1347-1353.
8. Chikanza IC, Petrou P, Kingsley G, Chrousos G, Panayi GS. 1992. Defective hypothalamic response to immune and inflammatory stimuli in patients with rheumatoid arthritis. Arthritis Rheum 35:1281-1288.
9. Crofford LJ, Kalogeras KT, Mastorakos G, Magiakou MA, Wells J, Kanik KS, Gold PW, Chrousos GP, Wilder RL. 1997. Circadian relationships between interleukin (IL)-6 and hypothalamic-pituitary-adrenal axis hormones: Failure of IL-6 to cause sustained hypercortisolism in patients with early untreated rheumatoid arthritis. J Clin Endocrinol Metab 82:1279-1283.
10. DeRijk R, Michelson D, Karp B, Petrides J, Galliven E, Deuster P, Paciotti G, Gold PW, Sternberg EM. 1997. Exercise and circadian rhythm-induced variations in plasma cortisol differen-tially regulate interleukin-1 beta (IL-1 beta), IL-6, and tumor necrosis factor-alpha (TNF alpha) production in humans: High sensitivity of TNF alpha and resistance of IL-6. J Clin Endocrinol Metab 82:2182-2191.
11. Deuster PA, Petrides JS, Singh A, Chrousos GP, Poth M. 2000. Endocrine response to high-intensity exercise: Dose-dependent effects of dexamethasone. J Clin Endocrinol Metab 85: 1066-1073.
12. Dubaniewicz A. 2010. Mycobacterium tuberculosis heat shock proteins and autoimmunity in sarcoidosis. Autoimmun Rev 9: 419-424.
13. Facco M, Cabrelle A, Teramo A, Olivieri V, Gnoato M, Teolato S, Ave E, Gattazzo C, Fadini GP, Calabrese F, Semenzato G, Agostini C. 2011. Sarcoidosis is a Th1/Th17 multisystem disorder. Thorax 66:144-150.
14. Gomez MT, Magiakou MA, Mastorakos G, Chrousos GP. 1993. The pituitary corticotroph is not the rate limiting step in the postoperative recovery of the hypothalamic-pituitary-adrenal axis in patients with Cushing syndrome. J Clin Endocrinol Metab 77:173-177.
15. Guntupova LD, Borisov SE, Kupavtseva EA, Mikhaîlova LP, Makarova OV. 2006. The cytokine profile in granulomatous lung diseases. Probl Tuberk Bolezn Legk 6:10-14, (Article in Russian).
16. Hesse DG, Tracey KJ, Fong Y, Manogue KR, Palladino MA, Jr, Cerami A, Shires GT, Lowry SF. 1988. Cytokine appearance in human and endotoxemia and primate bacteremia. Surg Gynecol Obset 166:147-153.
17. Hunninghake GW. 1984. Release of interleukin-1 by alveolar macrophages ofpatients with active pulmonary sarcoidosis. Am Rev Resp Dis 129:569-572.
18. Iannuzzi MC, Rybicki BA, Teirstein AS. 2007. Sarcoidosis. N Engl J Med 357:2153-2165.
19. Johnson EO, Vlachoyiannopoulos PG, Skopouli FN, Tzioufas AG, Moutsopoulos HM. 1998. Hypofunction of the stress axis in Sjogren's syndrome. J Rheumatol 25:1508-1514.
20. Luger A, Deuster PA, Kyle SB, Gallucci WT, Montgomery LC, Gold PW, Loriaux DL, Chrousos GP. 1987. Acute hypothala-mic-pituitary-adrenal responses to the stress of treadmill exercise. Physiologic adaptations to physical training. N Engl J Med 316:1309-1315.
21. Maniwa K, Ogushi F, Haku T, Sone S, Ohmoto Y. 1998. Sarcoidosis associated with acute renal failure and increased levels ofinterleukin-6 in urine. Intern Med 37:757-761.
22. Mastorakos G, Chrousos GP, Weber JS. 1993. Recombinant interleukin-6 activates the hypothalamic-pituitary-adrenal axis in humans. J Endocrinol Metab 77:1690-1694.
23. Mastorakos G, Ilias I. 2000. Relationship between interleukin-6 (IL-6) and hypothalamic-pituitary-adrenal axis hormones in rheumatoid arthritis. Z Rheumatol 59:75-79.
24. Mastorakos G, Pavlatou M. 2005. Exercise as a stress model and the interplay between the hypothalamus-pituitary-adrenal and the hypothalamus-pituitary-thyroid axes. Horm Metab Res 37: 577-584.
25. Mastorakos G, Pavlatou M, Diamanti-Kandarakis E, Chrousos GP. 2005. Exercise and the stress system. Hormones (Athens) 4: 73-89.
26. Mucida D, Park Y, Kim G, Turovskaya O, Scott I, Kronenberg M, Cheroutre H. 2007. Reciprocal TH17 and regulatory T cell differentiation mediated by retinoic acid. Science 317:256-260.
27. Neurath MF, Finotto S. 2011. IL-6 signaling in autoimmunity, chronic inflammation and inflammation-associated cancer. Cytokine Growth Factor Rev 22:83-89.
28. Ostrowski K, Hermann C, Bangash A, Schjerling P, Nielsen JN, Pedersen BK. 1998. A trauma-like elevation of plasma cytokines in humans in response to treadmill running. J Physiol (Lond) 513:889-894.
29. Papanicolaou DA, Petrides JS, Tsigos C, Bino S, Kalogeras KT, Wilder R, Gold PW, Deuster PA, Chrousos GP. 1996. Exercise stimulates interleukin-6 secretion: Inhibition by glucocorticoids and correlation with catecholamines. Am J Physiol 271: E601-E605.
30. Päth G, Scherbaum WA, Bornstein SR. 2000. The role of interleukin-6 in the human adrenal gland. Eur J Clin Invest 30: 91-95.
31. Pedersen BK. 2009. Edward F Adolph distinguished lecture: Muscle as an endocrine organ: IL-6 and other myokines. J Appl Physiol 107:1006-1014.
32. Pueringer RJ, Schwartz DA, Dayton CS, Gilbert SB, Hunninghake GW 1993. The relationship between alveolar-macrophage TNF, IL-1 and PGE2 release, alveolitis, and disease severity in sarcoidosis. Chest 103:832-838.
33. Reincke M, Heppner C, Petzke F, Allolio B, Arlt W, Mbulamberi D, Siekmann L, Vollmer D, Winkelmann W, Chrousos GP. 1994. Impairment ofadrenocortical function associated with increased plasma tumor necrosis factor-alpha and interleukin-6 concen-trations in African Trypanosomiasis. Neuroimmunomodulation 1:14-22.
34. Sahashi K, Ina Y, Takada K, Sato T, Yamamoto M, Morishita M. 1991. Significance of interleukin 6 in patients with sarcoidosis. Chest 106:156-160.
35. Sakito O, Kadota J, Kohno S, Abe K, Shirai R, Hara K. 1996. Interleukin 1 beta, tumor necrosis factor alpha, and inteleukin 8 in bronchoalveolar lavage fluid of patients with diffuse panbronchiolitis: Potential mechanism of macrolide therapy Respiration 63:42-48.
36. Silver JS, Hunter CA. 2010. gp130 at the nexus ofinflammation, autoimmunity, and cancer. J Leukoc Biol 88:1145-1156.
37. Späth-Schwalbe E, Born J, Schrezenmeier H, Bornstein SR, Stromeyer P, Drechsler S, Fehm HL, Porzsolt F. 1994. Interleukin-6 stimulates the hypothalamus-pituitary-adreno-cortiscal axis in man. J Clin Endocrinol Metab 79:1212-1214.
38. Steffen M, Petersen J, Oldings M, Karmeier A, Magnussen H, Thile HG, Reedler A. 1993. Increased secretion of tumor necrosis factor-alpha, interleukin-1 beta, and interleukin-6 by alveolar macrophages from patients with sarcoidosis. J Allergy Clin Immunol 91:939-949.
39. Suzuki K, Nakaji S, Yamada M, Totsuka M, Sato K, Sugawara K. 2002. Systemic inflammatory response to exhaustive exercise. Cytokine kinetics. Exerc Immunol Rev 8:6-48.
40. Takizawa H, Satoh M, Okazaki H, Matsuzaki G, Suzuki N, Ishii A, Suko M, Okudaira H, Morita Y, Ito K. 1997. Increased IL-6 and IL-8 in bronchoalveolar lavage fluids (BALF) from patients with sarcoidosis: Correlation with the clinical parameters. Clin Exp Immunol 107:175-181.
41. Tzioufas AG, Tsonis J, Moutsopoulos HM. 2008. Neuroendocrine dysfunction in Sjogren's syndrome. Neuroimmunomodulation. 15:37-45.
42. Ullum H, Haahr PM, Diamant M, Palmo J, Halkjaer-Kristensen J, Pedersen BK. 1994. Bicycle exercise enhances plasma IL-6 but does not change IL-1 alpha, IL-1 beta, IL-6, or TNF-alpha pre-mRNA in BMNC. J Appl Physiol 77:93-97.
43. Zietz B, Reber T, Oertel M, Glück T, Schölmerich J, Straub RH. 2000. Altered function of the hypothalamic stress axes in patients with moderately active systemic lupus erythematosus. II. Dissociation between androstenedione, cortisol, or dehy-droepindrosterone and interleukin 6 or tumor necrosis factor. J Rheumatol 27:911-918.
44. Zissel G, Prasse A, Müller-Quernheim J. 2010. Immunologic response to sarcoidosis. Semin Respir Crit Care Med. 31: 390-403.